VRAD, Korean virtual reality medical education company, expands into Asian Markets

11th September, 2024

To enable more medical institutions to leverage VRAD's innovative educational tools

image credit- shutterstock

image credit- shutterstock

VRAD, a leading company specializing in virtual reality medical education software, has officially announced its entry into the Asian market by launching a new series of medical education simulators. By introducing its flagship medical education simulators to these markets, VRAD is expanding its presence in key Asian countries, including Thailand, India, Taiwan, and Singapore.

The newly launched simulators include the ‘Core Nursing Skills Simulator,’ ‘Oral Radiography Simulator,’ ‘Severe Trauma Management Simulator,’ ‘Ventilator Management Simulator,’ and ‘Neonatal APGAR Scoring Simulator.’ Each simulator is meticulously designed to enable medical professionals to receive training in environments that closely mimic real-life scenarios.

VRAD is set to showcase these products at the Medical Fair Asia (MFA) in Singapore on September 11th. The company's innovative medical education solutions are expected to garner significant attention at this event, highlighting VRAD's growing influence in the Asian market. To date, VRAD has supplied its virtual reality medical education simulators to over 80 medical and educational institutions across Korea. The company anticipates that its entry into the Asian market will allow more medical institutions to leverage VRAD's innovative educational tools.

A VRAD representative stated, ‘This expansion into the Asian market is a pivotal step in VRAD's global growth strategy. The unveiling of our products at MFA in Singapore is particularly significant, as it will play a crucial role in strengthening our position in the Asian medical education sector.’

Designed to support real-time interaction and learning in virtual environments, VRAD's solutions aim to enhance the capabilities of medical professionals by preparing them for a wide range of medical scenarios.

© 2023 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer